Hutch News

Improving immunotherapy for advanced prostate cancer

Improving immunotherapy for advanced prostate cancer

Preclinical work identifies better target and recruits more immune cells to make CAR-T therapy work for solid tumors
Hutch NewsApril 27, 2023
Award will fund research into new metastatic prostate cancer therapies

Award will fund research into new metastatic prostate cancer therapies

Physician-scientist Dr. John Lee and his team will use $750K Kleberg Foundation grant to pursue new treatments, including immunotherapy
Hutch NewsOctober 21, 2022
Building better lab models of human tumors

Building better lab models of human tumors

Dr. John Lee receives $1.5M NIH New Innovator Award for creative young scientists with high-risk, high-reward projects
Hutch NewsOctober 05, 2021
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test

Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test

Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
Hutch NewsNovember 16, 2020
Experts discuss navigating cancer and cancer research during the pandemic

Experts discuss navigating cancer and cancer research during the pandemic

Hutch panelists offer their insights on how COVID-19 has impacted patients as well as their efforts to develop cancer treatments
Hutch NewsOctober 28, 2020